Cargando…
EZH2 is a potential prognostic predictor of glioma
The enhancer of zeste homologue 2 (EZH2) is a histone H3 lysine 27 methyltransferase that promotes tumorigenesis in a variety of human malignancies by altering the expression of tumour suppressor genes. To evaluate the prognostic value of EZH2 in glioma, we analysed gene expression data and correspo...
Autores principales: | Chen, Yi‐nan, Hou, Shi‐qiang, Jiang, Rui, Sun, Jun‐long, Cheng, Chuan‐dong, Qian, Zhong‐run |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812280/ https://www.ncbi.nlm.nih.gov/pubmed/33277782 http://dx.doi.org/10.1111/jcmm.16149 |
Ejemplares similares
-
High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
por: Wong, Yin Ping, et al.
Publicado: (2022) -
GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
por: Li, Ren, et al.
Publicado: (2022) -
Clinicopathological and Prognostic Significance of ABCC3 in Human Glioma
por: Fang, Dan-Dong, et al.
Publicado: (2021) -
Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study
por: Liu, Li, et al.
Publicado: (2013) -
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)